BIO972 Israel. Science. Community.

BioBlast Pharma (NASDAQ:ORPN) of Tel Aviv has been granted Orphan Drug status by the U.S. Food & Drug Administration (FDA) for its product candidate Cabaletta for the treatment of Spinocerebellar Ataxia Type 3 (also known as SCA3 or Machado-Joseph disease. This is the second ...

Loss of eyesight, often caused by retinal degeneration, is a common ailment as people age. Research published late last week in the American Chemical Society (ACS) journal Nano Letters shows that great progress has recently been made toward countering this life-changing ...

A new study at Weizmann Institute of Science in Rehovot shows that olfactory conditioning during sleep can affect changes in behavior. Published today in The Journal of Neuroscience, Dr. Anat Arzi of Prof. Noam Sobel‘s Olfaction Research group presented cigarette smokers who ...